Bruna Calsina
Overview
Explore the profile of Bruna Calsina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
638
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monteagudo M, Calsina B, Salazar-Hidalgo M, Martinez-Montes A, Pineiro-Yanez E, Caleiras E, et al.
Best Pract Res Clin Endocrinol Metab
. 2024 Sep;
38(6):101931.
PMID: 39218714
Pheochromocytomas and paragangliomas are rare neuroendocrine tumours. Around 20-25 % of patients develop metastases, for which there is an urgent need of prognostic markers and therapeutic stratification strategies. The presence...
2.
Moreno-Cabrera J, Feliubadalo L, Pineda M, Prada-Dacasa P, Ramos-Muntada M, Del Valle J, et al.
Database (Oxford)
. 2024 Jul;
2024.
PMID: 38965703
Accurate classification of genetic variants is crucial for clinical decision-making in hereditary cancer. In Spain, genetic diagnostic laboratories have traditionally approached this task independently due to the lack of a...
3.
Uher O, Hadrava Vanova K, Taieb D, Calsina B, Robledo M, Clifton-Bligh R, et al.
Endocr Rev
. 2024 Feb;
45(4):521-552.
PMID: 38377172
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors derived from neural crest cells from adrenal medullary chromaffin tissues and extra-adrenal paraganglia, respectively. Although the current treatment for PPGLs is surgery,...
4.
Li M, Richter S, Mohr H, Drukewitz S, Poser I, Stanke D, et al.
Endocr Relat Cancer
. 2023 Oct;
30(12).
PMID: 37902037
The biochemical phenotype of paragangliomas (PGLs) is highly dependent on the underlying genetic background and tumor location. PGLs at extra-adrenal locations usually do not express phenylethanolamine N-methyltransferase (PNMT), the enzyme...
5.
Roldan-Romero J, Valdivia C, Santos M, Lanillos J, Maroto P, Anguera G, et al.
Int J Cancer
. 2023 Jun;
153(6):1300-1312.
PMID: 37260183
Mammalian target of rapamycin (mTOR) is a central regulator of mammalian metabolism and physiology. Aberrant hyperactivation of the mTOR pathway promotes tumor growth and metastasis, and can also promote tumor...
6.
Mellid S, Garcia F, Leandro-Garcia L, Diaz-Talavera A, Martinez-Montes A, Gil E, et al.
Cancer Commun (Lond)
. 2023 May;
43(7):838-843.
PMID: 37139660
No abstract available.
7.
Calsina B, Pineiro-Yanez E, Martinez-Montes A, Caleiras E, Fernandez-Sanroman A, Monteagudo M, et al.
Nat Commun
. 2023 Feb;
14(1):1122.
PMID: 36854674
The mechanisms triggering metastasis in pheochromocytoma/paraganglioma are unknown, hindering therapeutic options for patients with metastatic tumors (mPPGL). Herein we show by genomic profiling of a large cohort of mPPGLs that...
8.
Cascon A, Calsina B, Monteagudo M, Mellid S, Diaz-Talavera A, Curras-Freixes M, et al.
J Mol Endocrinol
. 2022 Dec;
70(3).
PMID: 36520714
The genetics of pheochromocytoma and paraganglioma (PPGL) has become increasingly complex over the last two decades. The list of genes involved in the development of these tumors has grown steadily,...
9.
Bechmann N, Calsina B, Richter S, Pietzsch J
J Invest Dermatol
. 2022 Jan;
142(8):2217-2227.
PMID: 34990694
Malignant melanoma has a steadily increasing incidence, but treatment options are still limited, and the prognosis for patients, especially for men, is poor. To investigate whether targeting estrogen receptor (ER)...
10.
Monteagudo M, Martinez P, Leandro-Garcia L, Martinez-Montes A, Calsina B, Pulgarin-Alfaro M, et al.
Cancers (Basel)
. 2021 Oct;
13(19).
PMID: 34638246
One of the main problems we face with PPGL is the lack of molecular markers capable of predicting the development of metastases in patients. Telomere-related genes, such as and have...